Trials / Sponsors / Northwest Biotherapeutics
Northwest Biotherapeutics
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer Brain Metastases, Lung Cancer Metastatic, Breast Cancer Metastatic | Phase 1 | 2018-11-01 |
| Unknown | Safety and Efficacy Study of DCVax-Direct in Solid Tumors Locally Advanced Tumor, Metastatic Solid Tissue Tumors, Liver Cancer | Phase 1 / Phase 2 | 2013-06-01 |
| Unknown | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Glioblastoma Multiforme, Glioblastoma, GBM | Phase 3 | 2006-12-01 |
| Available | Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 0 GBM, Glioblastoma Multiforme | — | — |
| Withdrawn | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. Prostate Cancer | Phase 3 | — |